India’S Universal Immunization Programme (Uip): Vaccines, Schedule, Achievements and Challenges

India’s Universal Immunization Programme (UIP) ranks among the largest public health interventions globally, providing free vaccination against twelve vaccine-preventable diseases to target cohorts of children and pregnant women. Originating from the Expanded Programme on Immunization (EPI) launched by the Ministry of Health and Family Welfare in 1978, the initiative received its current nomenclature in 1985 when its scope expanded beyond urban centers into rural geographies. UIP forms a foundational pillar of the National Health Mission (NHM), targeting an annual cohort of approximately 2.6 crore infants and 2.9 crore pregnant women across the nation.

Administrative Evolution and Historical Trajectory

The journey of systematic immunization in independent India began with the Expanded Programme on Immunization in 1978, focusing initially on urban healthcare centers. The government converted EPI into the Universal Immunization Programme in 1985, extending coverage to rural districts and introducing phased implementation nationwide. In 1992, UIP became part of the Child Survival and Safe Motherhood (CSSM) Programme, later integrating into the Reproductive and Child Health (RCH) Programme in 1997. Following the launch of the National Rural Health Mission (NRHM) in 2005, immunization services merged into the primary public healthcare delivery framework.

Disease Coverage and Vaccine Portfolio

UIP guards against twelve vaccine-preventable diseases (VPDs). The government classifies these vaccines based on geographic reach into nationally administered vaccines and sub-nationally or endemic-region specific vaccines.

Nationally Administered Vaccines

• BCG (Bacillus Calmette-Guérin): Protects against childhood tuberculosis, specifically tubercular meningitis and disseminated TB.
• OPV (Oral Polio Vaccine): Protects against poliomyelitis caused by poliovirus types 1 and 3.
• fIPV (Fractional Inactivated Polio Vaccine): Administered intradermally to complement OPV and provide immunity against all three poliovirus serotypes.
• Hepatitis B: Protects against perinatal and early childhood Hepatitis B infection.
• Pentavalent Vaccine: Single combination vaccine protecting against five diseases: Diphtheria, Pertussis (whooping cough), Tetanus, Hepatitis B, and Haemophilus influenzae type b (Hib).
• Rotavirus Vaccine (RVV): Protects against severe rotavirus-induced diarrhea in infants.
• Pneumococcal Conjugate Vaccine (PCV): Protects against invasive pneumococcal disease, pneumonia, and meningitis caused by Streptococcus pneumoniae.
• MR (Measles-Rubella): Combination vaccine replacing monovalent measles vaccine to eliminate measles and Congenital Rubella Syndrome (CRS).
• DPT Booster: Protects against Diphtheria, Pertussis, and Tetanus at key childhood developmental milestones.
• Td (Tetanus and Adult Diphtheria): Replaced TT (Tetanus Toxoid) for pregnant women and adolescents to ensure dual protection against diphtheria and tetanus.

Sub-Nationally / Regionally Administered Vaccines

• Japanese Encephalitis (JE) Vaccine: Administered in 231 endemic districts across various states including Uttar Pradesh, Bihar, Assam, and West Bengal.

National Immunization Schedule

The National Immunization Schedule outlines specific vaccine dosages, delivery routes, and timeframes from birth through adolescence.

Key Supplementary Immunization Initiatives

Mission Indradhanush (MI)

Launched in December 2014, Mission Indradhanush identifies and vaccinates partially vaccinated and unvaccinated children and pregnant women in low-coverage pockets. The mission executes focused, time-bound drives using multi-phase catch-up campaigns.

Intensified Mission Indradhanush (IMI)

The Ministry of Health updated Mission Indradhanush through multiple operational phases:

• IMI 1.0 (2017): Targeted select high-priority districts and urban areas with full immunization coverage below 70%.
• IMI 2.0 (2019-20): Expanded focus to hard-to-reach areas and tribal blocks.
• IMI 3.0 (2021): Focused on catching up children who missed routine doses during the COVID-19 pandemic.
• IMI 4.0 (2022): Accelerated routine coverage toward the goal of full immunization coverage above 90%.
• IMI 5.0 (2023): Marked the first nationwide drive incorporating digital tracking through the eVIN and U-WIN platforms, focusing on children up to 5 years of age.

U-WIN Digital Platform

U-WIN operates as the central digital registry modeled after the Co-WIN portal. It digitizes the entire immunization lifecycle, maintaining an electronic record of every pregnant woman and child, tracking vaccination appointments, sending SMS reminders, and generating verifiable digital certificates.

Electronic Vaccine Intelligence Network (eVIN)

eVIN digitizes vaccine logistics and cold chain management. Implemented across all states and UTs, it provides real-time data on vaccine stock positions and temperature monitoring inside cold chain points using internet-connected sensors.

Cold Chain Infrastructure and Logistics

UIP uses a multi-tiered cold chain distribution network to preserve vaccine potency from manufacturing plants down to session sites.

• Primary Storage Points: Government Medical Store Depots (GMSDs) and State Vaccine Stores.
• Secondary Storage Points: Regional and District Vaccine Stores equipped with Walk-in Coolers (WICs) and Walk-in Freezers (WIFs).
• Tertiary Storage Points: Community Health Centres (CHCs) and Primary Health Centres (PHCs) equipped with Ice-Lined Refrigerators (ILRs) and Deep Freezers.
• Last-Mile Transport: Cold boxes and insulated vaccine carriers carrying conditioned ice packs deliver vaccines to village-level session sites managed by Auxiliary Nurse Midwives (ANMs) and Accredited Social Health Activists (ASHAs).

Major Achievements and Milestones

• Smallpox Eradication: Declared smallpox-free in 1977 following intensive containment strategies.
• Polio Elimination: India received official Polio-free certification from the World Health Organization (WHO) on March 27, 2014, alongside the South-East Asia Region, after recording zero wild poliovirus cases since January 13, 2011 (Howrah, West Bengal).
• Maternal and Neonatal Tetanus Elimination (MNTE): Declared MNTE-compliant by WHO in May 2015, validated well before global deadlines.
• Full Immunization Coverage (FIC): Expanded national FIC rates from under 40% in early survey rounds to over 76% under National Family Health Survey (NFHS-5) data.
• Indigenous Manufacturing Capability: Transitioned from import dependency to domestic self-reliance for major vaccines, including BCG, OPV, Rotavirus, and Hepatitis B.

Operational Challenges and Impediments

• Regional and Socio-Economic Disparities: Varied coverage rates persist between urban slums, remote tribal hamlets, and accessible plain regions.
• Vaccine Hesitancy and Misinformation: Localized rumors, religious misgivings, and fear of Adverse Events Following Immunization (AEFI) lower uptake in specific districts.
• Cold Chain Maintenance Gaps: Power outages in rural primary health centers put temperature-sensitive vaccines at risk of thermal degradation.
• Migration Dynamics: Seasonal migrant families frequently miss multi-dose vaccine schedules due to lack of cross-boundary tracking mechanisms across states.
• Data Integration Friction: Transitioning frontline workers from paper registers to the digital U-WIN system requires continuous field training and stable internet connectivity.

Essential Facts for Quick Revision

• Expanded Programme on Immunization (EPI) started in India in 1978 and became the Universal Immunization Programme (UIP) in 1985.
• UIP protects against 12 diseases: Diphtheria, Pertussis, Tetanus, Polio, Tuberculosis, Hepatitis B, Meningitis and Pneumonia caused by Hib, Rotavirus Diarrhea, Pneumococcal Disease, Measles, Rubella, and Japanese Encephalitis.
• Japanese Encephalitis vaccine is administered only in designated endemic districts.
• India received Polio-free certification on March 27, 2014; the last wild poliovirus case occurred in Howrah, West Bengal on January 13, 2011.
• Maternal and Neonatal Tetanus Elimination (MNTE) status was validated in India in May 2015.
• Mission Indradhanush was launched on December 25, 2014 to target unvaccinated and partially vaccinated children.
• U-WIN portal serves as the digital registry for capturing every vaccination transaction for pregnant women and children.
• eVIN (Electronic Vaccine Intelligence Network) tracks real-time vaccine stocks and storage temperatures across all cold chain points.
• Td vaccine replaced Tetanus Toxoid (TT) in the national schedule to protect against adult diphtheria along with tetanus.
• Fractional IPV (fIPV) is given intradermally at 6 weeks and 14 weeks of age to stretch vaccine supplies and boost immunity.